Author:
Bangma Chris,Doan Paul,Zhu Lin,Remmers Sebastiaan,Nieboer Daan,Helleman Jozien,Roobol Monique J.,Sugimoto Mikio,Chung Byung Ha,Lee Lui Shiong,Frydenberg Mark,Klotz Laurence,Peacock Michael,Perry Antoinette,Bjartell Anders,Rannikko Antti,Van Hemelrijck Mieke,Dasgupta Prokar,Moore Caroline,Trock Bruce J.,Pavlovich Christian,Steyerberg Ewout,Carroll Peter,Koo Kyo Chul,Hayen Andrew,Thompson James
Reference66 articles.
1. Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer;Hamdy;N Engl J Med,2023
2. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent;Mottet;Eur Urol,2021
3. Active surveillance for men younger than 60 years or with intermediate-risk localized prostate cancer. descriptive analyses of clinical practice in the Movember GAP3 initiative;Remmers;Eur Urol Open Sci,2022
4. Papa N, O’Callaghan M, Mark S, Millar J, Breen S. Prostate cancer across Australia and New Zealand: PCOR-ANZ 2015–2019 summary report, October 2022. Prostate Cancer Outcomes Registry Australia and New Zealand (PCOR-ANZ); 2022.
5. National Prostate Cancer Audit NPC. NPCA annual report 2021. 2021.